Lv31
250 积分 2022-05-07 加入
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
6小时前
待确认
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
5个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
5个月前
已完结
Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer
9个月前
已完结
Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
9个月前
已完结
Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
9个月前
已完结
非小细胞肺癌新辅助治疗疗效病理评估专家共识
10个月前
已完结
Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy
10个月前
已关闭
放化疗结合靶向治疗非小细胞肺癌脑转移的临床分析
10个月前
已关闭
[Consensus on clinical diagnosis, treatment, and prevention of chemotherapy-induced neutropenia in China (2023 edition)]
10个月前
已完结
皖公网安备34019202002308
